Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?
There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.
San Jose Launches First-In-The-Country Addiction Treatment Program for Teens
The Santa Clara County Valley Medical Center is setting the gold standard in comprehensive care for teens suffering from substance use disorders.
The Next Best Thing to Wasted
Food coma has the same effect that opiate addicts crave — escape from the bonds of consciousness. Oblivion. Erasure of the environment.
Seattle Testing Contingency Management for the Treatment of Substance Use Disorders
A pilot project brings contingency management to the streets of Seattle in an effort to curb overdose deaths.
A Revolution in Treatment for Substance Use Disorders
More than a dozen startup companies are in competition to perfect telehealth addiction treatment programs.
Polysubstance Abuse: The Changing Shape of the Opioid Crisis
Synthetic opioids such as fentanyl are causing a third wave of polysubstance abuse and overdose deaths.